Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial.

ABSTRACT:

Importance

The optimal configuration of a smoking cessation intervention in a lung cancer screening (LCS) setting has not yet been established.

Objective

To evaluate the efficacy of 3 tobacco treatment strategies of increasing integration and intensity in the LCS setting.

Design, setting, and participants

In this randomized clinical trial, LCS-eligible current smokers were randomized into 3 treatments: quitline (QL), QL plus (QL+), or integrated care (IC). The study was conducted from July 2017 to June 2022 at a hospital-based tobacco treatment clinic in Houston, Texas.

Interventions

The QL intervention group had quitline referral and 12-week nicotine replacement therapy (NRT). The QL+ group had quitline referral plus 12-week NRT or pharmacotherapy prescribed b

SUBMITTER: Cinciripini PM 

PROVIDER: S-EPMC11877161 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature